COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Atrial Fibrillation Management: How Do We Implement “Risk Factor Mod…

ARCH Advanced Revascularization Symposium

J. Mandrola

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

BMFcases

T. Bat, M. Carrier

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Keck School of Medicine of USC

L. Clavijo

Catheter Wars: The Thrombus Strikes Back

AVA 2022 Annual Scientific Meeting

A. Bulmer, P. Carr

Thrombus Extending into the IVC

Venous Symposium

P. Muck

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Antiarrhythmic Drugs for AF in the Outpatient Setting

Mayo Clinic Proceedings

C. Desimone

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Upper Extremity Point of Care Ultrasound (POCUS)

UC San Diego Health - Hemophilia and Thrombosis Treatment Center

T. Sekayan

Duration of Anticoagulation: Provoked vs Unprovoked VTE

PERT Consortium 2022

G. Barnes

Diagnostic Work-up for Syncope and Arrhythmia

Scripps Health

J. Rogers